{"id":47132,"date":"2022-08-10T13:01:47","date_gmt":"2022-08-10T11:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/"},"modified":"2022-08-10T13:01:47","modified_gmt":"2022-08-10T11:01:47","slug":"global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/","title":{"rendered":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5635974\/global-oncology-drugs-market-2022-2027-by-drug?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wv6pnv&amp;utm_campaign=1736645+-+Global+Oncology+Drugs+Market+Report+2022-2027%3A+Growing+Prevalence+of+Cancer+%26+Rise+in+Government+Expenditure+on+Healthcare+Driving+Expansion&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing at a CAGR of 7.47%.\n<\/p>\n<p>\n<strong>Market Segmentations<\/strong>\n<\/p>\n<p>\nThe Global Oncology Drugs Market is segmented based on Drug Class, Indication, End-user, and Geography.\n<\/p>\n<ul>\n<li>\nBy Drug Class, the market is classified into Chemotherapy, Targeted therapy, Immunotherapy, and Hormonal therapy.\n<\/li>\n<li>\nBy Indication, the market is classified into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophageal cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers.\n<\/li>\n<li>\nBy End-user, the market is classified into Hospitals, Clinics, and Others.\n<\/li>\n<li>\nBy Geography, the market is classified into Americas, Europe, Middle-East &amp; Africa and Asia-Pacific.\n<\/li>\n<\/ul>\n<p>\n<strong>Countries Studied<\/strong>\n<\/p>\n<ul>\n<li>\nAmerica (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)\n<\/li>\n<li>\nEurope (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)\n<\/li>\n<li>\nMiddle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)\n<\/li>\n<li>\nAsia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)\n<\/li>\n<\/ul>\n<p>\n<strong>Competitive Quadrant<\/strong>\n<\/p>\n<p>\nThe report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\n<\/p>\n<p>\n<strong>Ansoff Analysis<\/strong>\n<\/p>\n<p>\nThe report presents a detailed Ansoff matrix analysis for the Global Oncology Drugs Market. Ansoff Matrix, also known as Product\/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Oncology Drugs Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.\n<\/p>\n<p>\n<strong>Why buy this report?<\/strong>\n<\/p>\n<ul>\n<li>\nThe report offers a comprehensive evaluation of the Global Oncology Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.\n<\/li>\n<li>\nThe report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.\n<\/li>\n<li>\nThe report includes an in-depth market analysis using Porter&#8217;s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.\n<\/li>\n<li>\nThe report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.\n<\/li>\n<li>\nThe report also contains the competitive analysis using Positioning Quadrants, the analyst&#8217;s Proprietary competitive positioning tool.\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights:<\/strong>\n<\/p>\n<ul>\n<li>\nA complete analysis of the market, including the parent industry\n<\/li>\n<li>\nImportant market dynamics and trends\n<\/li>\n<li>\nMarket segmentation\n<\/li>\n<li>\nHistorical, current, and projected size of the market based on value and volume\n<\/li>\n<li>\nMarket shares and strategies of key players\n<\/li>\n<li>\nRecommendations to companies for strengthening their foothold in the market\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nGrowing Prevalence of Cancer\n<\/li>\n<li>\nIncrease in Geriatric Population\n<\/li>\n<li>\nRise in Government Expenditure on Healthcare\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nHigh Cost Involved in New Drug Development\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nIncreasing Adaptation in Emerging countries\n<\/li>\n<li>\nGrowing Number of Pipeline Drugs\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nIssues arising out of using Cancer Drugs<\/p>\n<p>\n\u00a0\n<\/p>\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Report Description<\/strong>\n<\/p>\n<p>\n<strong>2 Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong>5 Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>6 Global Oncology Drugs Market, By Drug Class<\/strong>\n<\/p>\n<p>\n<strong>7 Global Oncology Drugs Market, By Indication<\/strong>\n<\/p>\n<p>\n<strong>8 Global Oncology Drugs Market, By End-user<\/strong>\n<\/p>\n<p>\n<strong>9 Americas&#8217; Oncology Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>10 Europe&#8217;s Oncology Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>11 Middle East and Africa&#8217;s Oncology Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>12 APAC&#8217;s Oncology Drugs Market<\/strong>\n<\/p>\n<p>\n<strong>13 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>14 Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>15 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nF. Hoffmann-La Roche AG\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nBristol-Myers Squibb Company\n<\/li>\n<li>\nMerck &amp; Co., Inc Johnson &amp; Johnson\n<\/li>\n<li>\nAbbVie Inc Amgen\n<\/li>\n<li>\nAstellas Pharma Inc AstraZeneca PLC\n<\/li>\n<li>\nPfizer Inc\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5635974\/global-oncology-drugs-market-2022-2027-by-drug?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wv6pnv&amp;utm_campaign=1736645+-+Global+Oncology+Drugs+Market+Report+2022-2027%3A+Growing+Prevalence+of+Cancer+%26+Rise+in+Government+Expenditure+on+Healthcare+Driving+Expansion&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/sb40vk<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x70;r&#101;&#x73;s&#64;&#x72;e&#115;&#x65;a&#114;&#x63;h&#97;&#x6e;d&#109;&#x61;r&#107;&#x65;t&#115;&#x2e;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#x72;&#101;s&#x65;&#x61;&#x72;&#99;h&#x61;&#x6e;&#x64;&#109;a&#x72;&#x6b;&#x65;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47132","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-10T11:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-10T11:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/\"},\"wordCount\":811,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220810005407\\\/en\\\/1540523\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/\",\"name\":\"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220810005407\\\/en\\\/1540523\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-10T11:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220810005407\\\/en\\\/1540523\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220810005407\\\/en\\\/1540523\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-10T11:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion &#8211; ResearchAndMarkets.com","datePublished":"2022-08-10T11:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/"},"wordCount":811,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/","name":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg","datePublished":"2022-08-10T11:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220810005407\/en\/1540523\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-drugs-market-report-2022-2027-growing-prevalence-of-cancer-rise-in-government-expenditure-on-healthcare-driving-expansion-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Oncology Drugs Market Report 2022-2027: Growing Prevalence of Cancer &amp; Rise in Government Expenditure on Healthcare Driving Expansion &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47132"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47132\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}